Gloria Brombo

Via Luigi Borsari 46
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia.

Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia.

Journal: Antioxidants (Basel, Switzerland)

Published: July 03, 2026

Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?

Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?

Journal: Aging clinical and experimental research

Published: February 04, 2026

Predictive factors for hospitalization in patients on integrated home care program.

Predictive factors for hospitalization in patients on integrated home care program.

Journal: Public health

Published: December 05, 2025

Effectiveness of acetylcholinesterase inhibitors and memantine in patients affected by severe dementia.

Effectiveness of acetylcholinesterase inhibitors and memantine in patients affected by severe dementia.

Journal: GeroScience

Published: October 16, 2025

Long-Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia.

Long-Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia.

Journal: International journal of geriatric psychiatry

Published: July 10, 2025

Prevalence and clinical significance of loneliness in older patients admitted to acute hospital wards.

Prevalence and clinical significance of loneliness in older patients admitted to acute hospital wards.

Journal: The journal of nutrition, health & aging

Published: June 06, 2025

Sex-difference in the association between Triglyceride-Glucose (TyG) index and dementia.

Sex-difference in the association between Triglyceride-Glucose (TyG) index and dementia.

Journal: Journal of diabetes and metabolic disorders

Published: April 25, 2025

Cerebral Blood Flow in Alzheimer's Disease: A Meta-Analysis on Transcranial Doppler Investigations.

Cerebral Blood Flow in Alzheimer's Disease: A Meta-Analysis on Transcranial Doppler Investigations.

Journal: Geriatrics (Basel, Switzerland)

Published: December 03, 2023

Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study.

Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study.

Journal: GeroScience

Published: November 20, 2023

Variability in Alzheimer's disease mortality from European vital statistics, 2012-2020.

Variability in Alzheimer's disease mortality from European vital statistics, 2012-2020.

Journal: International journal of geriatric psychiatry

Published: November 14, 2023

High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.

High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.

Journal: Neurochemistry international

Published: October 13, 2023

Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease.

Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease.

Journal: Aging clinical and experimental research

Published: August 29, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026